Advanced Search
Contact | Corporate | Help

News Archive of Pharma News - Business Wire

ArticleAdded
Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics05-24-12
???????????????????????????05-24-12
Research and Markets: Introducing the 2012 Top 50 Developers of Pain Management Pharmaceuticals on a Worldwide Basis05-24-12
Resumen: Medochemie Ltd concluye la rápida implementación en la nube del premiado CRM, Mobile Intelligence y la base de datos líder mundial OneKey TM de Cegedim Relationship Management impulsando el crecimiento en sus principales mercados05-24-12
Medochemie Ltd kurbelt Wachstum in Schlüsselmärkten durch schnelle Implementierung der preisgekrönten* cloudbasierten CRM-Lösung Mobile Intelligence und der weltweit führenden Datenbank OneKey? von Cegedim Relationship Management an05-24-12
Riassunto: Per trainare la crescita nei mercati più importanti, Medochemie Ltd implementa rapidamente Mobile Intelligence di Cegedim, la premiata* soluzione di Relationship Management basata su cloud e il database OneKey? leader mondiale05-24-12
Medochemie Ltd Rapidly Deploys Cegedim Relationship Management's Award Winning*, Cloud-Based Mobile Intelligence and World Leading OneKey? Database to Drive Growth in Key Markets05-24-12
Gilead vraagt Europese marktapplicatie aan voor stimuleringsmiddel Cobicistat05-24-12
Gilead presenta solicitud de comercialización en Europa para el agente fármacoimpulsor cobicistat05-24-12
Research and Markets: Pain Partnering 2007-2012 Report Provides the Reader with an In-Depth Understanding and Access to Pain Trends and Structure of Deals05-24-12
Bristol-Myers Squibb to Take Part in Sanford Bernstein's 28th Annual Strategic Decisions Conference05-24-12
Dyax Launches HAE Diagnostic Testing Refund Program to Encourage Proper Diagnosis and Disease Management05-24-12
NeuroMetrix Engages IRG for Investor Relations05-24-12
Research and Markets: 2012 Report on the $220 Billion US Drug Stores Market featuring Walgreens, CVS Caremark and Rite Aid05-24-12
Xarelto's Once-Daily Dosing and Lack of Monitoring Requirements are Perceived by Physicians as Its Greatest Advantages Compared to Other Agents for Stroke Prevention in Atrial Fibrillation, According to a Recent BioTrends Report05-24-12
Consolidation in the PBM Market Creates Opportunity05-24-12
Transgenomic Acquires Clinical Sample Biorepository from Gene Logic05-24-12
Vertex Appoints David Altshuler, M.D., Ph.D., to its Board of Directors05-24-12
New Study Finds Online Training More Effective for Regulatory Compliance05-24-12
Samenvatting: PSE: nieuwe technologie heeft potentie om farmaproductie te transformeren05-24-12
Gilead reicht Europäischen Marktantrag für Arzneimittelverstärker Cobicistat ein05-24-12
Gilead dépose une demande d?autorisation de mise sur le marché en Europe pour l?agent amplificateur Cobicistat05-24-12
LABA/ICS Fixed-Dose Combinations Are the Most Commonly Prescribed Maintenance Therapies for Newly Diagnosed COPD Patients05-24-12
White Paper by Global Advertising Strategies Explores the Importance of Patient-Pharmacist Interaction among Hispanic Patients and Caregivers05-24-12
Text Message Prescription Reminders Significantly Improve Patient Adherence to Oral Diabetes Medication05-24-12
AlCana Comments on Rulings Made in Civil Suit05-24-12
Boston CEO Conference to Feature CEOs of Alkermes, Alnylam, Ariad, Biogen, Cubist, Genzyme, Millennium, Momenta, Sirtris, and Others June 11th and 12th05-24-12
XenoPort Submits Investigational New Drug Application for XP23829 as a Potential Treatment of RRMS05-24-12
Blueprint Medicines Welcomes Fidelity Biosciences to Investor Syndicate05-24-12
Galderma Italie déploie la solution primée* Mobile Intelligence pour iPad? de Cegedim Relationship Management, en mode Cloud et la base de données OneKey05-24-12
Research and Markets: Sarcopenia - Pipeline Review, H1 201205-24-12
Patterson Companies Reports Improved Fourth Quarter and Fiscal 2012 Operating Results05-24-12
Hanna Instruments, Inc.????????????????????????????05-24-12
??? ????????????????????????????????????????????????????05-24-12
Gilead deposita la domanda di autorizzazione alla commercializzazione dell?agente potenziatore Cobicistat in Europa05-23-12
Celldex's CDX-011 Demonstrates High Response Rates in Patients with Metastatic Breast Cancer Expressing Elevated Levels of GPNMB and in Triple Negative Disease05-23-12
Gilead Files European Marketing Application for Boosting Agent Cobicistat05-23-12
Baxter to Present at Goldman Sachs 33rd Annual Global Healthcare Conference05-23-12
Teva to Host Conference Call and Webcast on May 24, 201205-23-12
Don?t Let the Bedbugs Bite, or No One Sleeps Tight05-23-12
Dr. Bob Sears Shares ?What to Expect? as a New Parent05-23-12
NeuroMetrix to Exhibit at AACE Annual Meeting05-23-12
ISR's New Report Uncovers Barriers and Strategies in Investigator Recruitment05-23-12
PHT Corporation to Convene Global Biopharmaceutical Clinical Research Leaders at 16th Annual PRO & ePRO Congress05-23-12
KIYATEC Announces Initial Close on Series A Funding Round05-23-12
New Health Report da Quintiles avalia a equação de risco na medicina biofarmacêutica05-23-12
Quintiles? New Health Report bewertet Risikogleichung in der biopharmazeutischen Medizin05-23-12
The New Health Report évalue l?équation du risque en médecine biopharmaceutique05-23-12
Hanna Instruments, Inc. Launches Redesigned Scientific Analytical Bench-Top Meters with Improved Usability and Compact, Space Saving Design05-23-12
Hanna Instruments, Inc. Lança Medidores Analíticos Científicos de Bancada Reprojetados com Melhor Usabilidade e Modelo Compacto, Econômico em Espaço05-23-12
Hanna Instruments, Inc. lanza sus medidores de mesa de trabajo científico-analíticos rediseñados, con facilidad de uso mejorada y un diseño compacto para ahorrar espacio05-23-12
The Avoca Group Holds Quality Summit to Debate Adoption of Quality Standards05-23-12
Radioembolization Spheres to See Strong Growth in China Through 201605-23-12
Alnylam and PBL Sign License Agreement for Baulcombe & Hamilton RNAi Patent05-23-12
Iroko Pharmaceuticals Engages SynopiaRx to Navigate Managed Care Landscape05-23-12
Since the Dialysis Bundle Legislation Was Implemented in January 2011, Bundling Appears to Have Limited Impact on Medications Used for Dialysis Patients According to a Recent BioTrends Chart Study05-23-12
Therapure Biopharma Receives BIOTECanada Gold Leaf Award05-23-12
Senesco's SNS01 is a Potent Regulator of Programmed Cell Death and Tumor Growth in Murine Models of Multiple Myeloma05-23-12
BioTime and Subsidiary LifeMap Sciences, Inc. Announce Release of GeneCards® Version 3.0805-23-12
Dr. Annalisa Jenkins, Executive Vice President, Head of Global Drug Development and Medical for Merck Serono, Honored by Gilda's Club New York City05-23-12
Seattle Genetics Announces Health Canada Accepts ADCETRIS® New Drug Submission for Review05-23-12
APP Pharmaceuticals Acquires Three Products from Nexus05-23-12
Millennium and Takeda Announce Presentations for Key Investigational Molecules at American Society of Clinical Oncology Annual Meeting05-23-12
El Nuevo Informe sobre Salud de Quintiles Evalúa la Ecuación de Riesgo en la Medicina Biofarmacéutica05-23-12
Research and Markets: Myeloproliferative Disorders Global Clinical Trials Review, H1, 201205-23-12
Cold Spring Harbor Laboratory Joins the Illumina Genome Network05-23-12
AVEO Initiates Phase 1 Study of AV-203, an ERBB3 Inhibitory Antibody, in Advanced Solid Tumors05-23-12
Research and Markets: Analysis of Aggregates and Particles in Protein Pharmaceuticals05-23-12
Samenvatting: Hanna Instruments lanceert opnieuw ontworpen analytische Bench-Top Meters met een beter gebruiksgemak05-23-12
Research and Markets: Injectable Antibodies. Products, Markets, Players and Forecasts05-23-12
XDx and LabCorp Enter Into Collaboration and License Agreement to Develop Lupus Flare Predictor Test05-23-12
Pfizer Names Olivier Brandicourt as President and General Manager, Emerging Markets and Established Products Business Units05-23-12
PPD Names David Simmons Chairman and CEO05-23-12
Riassunto: Hanna Instruments, Inc. lancia una serie di misuratori da banco analitici e scientifici dal nuovo design e dal formato speciale e compatto per migliorare l'usabilità e risparmiare spazio05-23-12
Hanna Instruments, Inc. lance des appareils de mesure scientifiques de table reconfigurés avec une convivialité améliorée et une conception compacte et peu encombrante05-23-12
Hanna Instruments, Inc. führt neu gestaltete, kompakte, für wissenschaftliche Zwecke geeignete Tisch-Analysegeräte mit größerem Bedienkomfort und geringerem Platzbedarf ein05-23-12
?100,000 In Reward Donations for Projects Fundraising to Prevent Atrial Fibrillation-Related Strokes05-23-12
L?Oreal Active Cosmetics Division Deploys Cegedim Relationship Management's Award Winning* Mobile Intelligence CRM in India05-23-12
Deltagen Reports 2012 First Quarter Financial Results05-22-12
PSI Announces New Leadership in Latin America05-22-12
SunLink Health Systems, Inc. Amends Fiscal 2011 Annual Report on Form 10-K and Previously Filed Quarterly Reports on Form 10-Q05-22-12
Samenvatting: Quintiles nieuwe gezondheidsrapport evalueert de risicovereffening bij biofarmaceutische medicijnen05-22-12
Covidien Announces Pricing of $1.250 Billion Senior Notes Offering05-22-12
Celgene Corporation to Present at Sanford C. Bernstein's 28th Annual Strategic Decisions Conference05-22-12
CORRECTING and REPLACING Peru's Largest Pharmacy Chain InkaFarma, Selects and Implements LogFire Cloud Based SAAS WMS to Gain Efficiency and Productivity05-22-12
Apofore Founder Publishes Studies Identifying Apolipoprotein A-IV as New Potential Target for Type 2 Diabetes Therapeutics05-22-12
Impax Laboratories Announces Voting Results from 2012 Annual Meeting of Stockholders05-22-12
Research and Markets: Orphan Disease Therapeutics Market to 2018 - Big Pharma to Target Orphan Diseases05-22-12
Guardian Pharmacy LLC Announces Opening of Atlanta Long-term Care Pharmacy05-22-12
Riassunto: L'ultima relazione di Quintiles sulla salute pubblica analizza l'equazione di rischio nella medicina biofarmaceutica05-22-12
Research and Markets: The US Is Expected To Lead the OTC Pharmaceuticals Industry in the G8 Nations with a Value of $32,613.4 Million in 2016 Says Latest Report05-22-12
Research and Markets: Pediatric Non-Clinical Drug Testing: Principles, Requirements, and Practice05-22-12
Merck Announces Third-Quarter 2012 Dividend05-22-12
Research and Markets: 2012 Report on the $200 Billion US Pharmaceutical Manufacturing Industry05-22-12
Boehringer Ingelheim Announces Positive Phase II Results for Once-Daily Tiotropium in Asthma05-22-12
Research and Markets: Pharmacotherapy of Child and Adolescent Psychiatric Disorders, 3rd Edition05-22-12
Research and Markets: Chitosan-Based Systems for Biopharmaceuticals: Delivery, Targeting and Polymer Therapeutics05-22-12
Covidien Announces Senior Notes Offering and Redemption of 5.450% Senior Notes Due October 201205-22-12
France Biotech Presents the Results of Its 10th ?Life Science Panorama? for 2011, Compiled in Partnership with Ernst & Young05-22-12
Research and Markets: Choroidal Neovascularization - Pipeline Review, H1 201205-22-12
Samenvatting: New England Journal of Medicine publiceert nieuwe analyse risico stratificatie voor TYSABRI05-22-12
Research and Markets: Shionogi Inc.: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report05-22-12
Pfizer Invites Public to View and Listen to Webcast of June 3 Pfizer Analyst and Investor Meeting at ASCO05-22-12
House Action Aims to Protect TRICARE05-22-12
Camargo Appoints K. Gary Barnette as Vice President of Drug Development05-22-12
Wellstat Grants BTG European Distribution Rights to Investigational Antidote for 5-FU Overexposure05-22-12
Celtic Pharma Announces Successful Completion of Phase I/II study of Xerecept® in Pediatric Patients with Cerebral Tumors05-22-12
Alvine Pharmaceuticals Presents Results from a Phase 2A Trial of ALV003 in Celiac Disease Patients at the 2012 Digestive Diseases Week Meeting05-22-12
EnVivo Pharmaceuticals Appoints Alfred Sandrock, M.D., Ph.D., to Board of Directors05-22-12
Quintiles? New Health Report Evaluates the Risk Equation in Biopharmaceutical Medicine05-22-12
Pharmacokinetics Parameters of Sunshine Biopharma's Lead Anti-Cancer Compound Exceed Expectations05-22-12
Accumetrics Sees Significantly Increased Interest in VerifyNow P2Y12 Test as Plavix® Loses Patent Protection05-22-12
BioTime and Subsidiary LifeMap Sciences, Inc. Announce Agreement to Market MalaCards - A Database of Human Diseases05-22-12
Emergent BioSolutions to Present at Jefferies 2012 Global Healthcare Conference05-22-12
Research and Markets: Anesthesia Drugs Market (2011 - 2015) - U.S. Market Entry Study05-22-12
POZEN to Present at the Jefferies 2012 Global Healthcare Conference05-22-12
Isogenica Partners with CTC Laboratory Systems to Secure Business Development and Customer Support Operations in Japan05-22-12
Systagenix Presents New Evidence at EWMA 2012 Which Confirms the Importance of a New Test in Routine Clinical Practice to Determine EPA in Chronic Wounds05-22-12
???????????????????????????EPA????????????????????EWMA2012???????05-22-12
Systagenix presenta nueva evidencia en EWMA 2012 que confirma la importancia de una nueva prueba en la práctica clínica habitual para determinar la EPA en heridas crónicas05-22-12
Phagenesis Wins c. £1 million Translation Award by Wellcome Trust to Expand Dysphagia Treatment05-22-12
France Biotech dévoile les résultats de la dixième édition de son « Panorama des Sciences de la vie » 2011, réalisée en partenariat avec Ernst & Young05-22-12
Riassunto: Systagenix presenta nuove prove durante l'evento EWMA 2012 a conferma dell'importanza di un nuovo tipo di test nelle pratiche cliniche di routine per determinare l'elevata attività della proteasi nelle ferite croniche05-22-12
Systagenix??EWMA 2012??????????????????????EPA????????????????05-22-12
Samenvatting: Systagenix: nieuwe test belangrijk voor bepaling hoge protease activiteit (EPA) bij chronische wonden05-22-12
Systagenix présente de nouvelles preuves au congrès EWMA 2012 confirmant l?importance d?un nouveau test dans la pratique clinique courante afin de déterminer l?EPA des plaies chroniques05-22-12
Systagenix präsentiert neue Erkenntnisse auf der EWMA 2012, die die Bedeutung eines neuen Testverfahrens zur Bestimmung von EPA in chronischen Wunden in der klinischen Routinepraxis bestätigen05-22-12
A Systagenix apresenta uma Nova Evidência na EWMA 2012, que Confirma a Importância de um Novo Teste para determinar EPA em Feridas Crónicas, na Prática Clínica de Rotina05-22-12
e-Therapeutics? Preliminary Results for the Year Ended 31 January 201205-22-12
Mirna Therapeutics Presents Updates on Development Program for Lead Therapeutic Candidate05-22-12
One million signatures needed to call upon World Health Organization to save lives through education and improved management of atrial fibrillation05-22-12
Sucampo Presents Detailed Results of Positive Phase 3 Trial of Lubiprostone in Opioid-Induced Bowel Dysfunction (OBD)05-21-12
Noven Confirms Filing of Abbreviated New Drug Application for Generic Lidocaine Patch 5%05-21-12
Early and Late Stage Innovators and Investors Meet at C21 BioVentures in Napa Valley05-21-12
SunLink Health Systems, Inc. Announces Fiscal 2012 Third Quarter and Nine Month Results05-21-12
Virginia Bio Names Jeffrey M. Gallagher Interim Executive Director05-21-12
Covidien Appoints Gregory S. Andrulonis Vice President and Treasurer05-21-12
Verastem to Host NASDAQ Opening in its Cambridge Laboratory May 22, 201205-21-12
IVAX Diagnostics, Inc. Reports First Quarter 2012 Financial Results05-21-12
Boehringer Ingelheim's once-daily bronchodilator olodaterol* successfully completes Phase II clinical trial program in COPD05-21-12
Pulmatrix Announces Presentation of Clinical Data Demonstrating iCALM Inhaled Therapeutic Reduced Airway Inflammation05-21-12
High School Students Named Winners in Local Biotechnology Research Competition05-21-12
AB SCIEX Launches the World's Most Sensitive Mass Spectrometer to Achieve the Lowest Limits of Quantitation in Complex Matrices05-21-12
AB SCIEX Launches Next-generation TripleTOF? 5600 System05-21-12
AB SCIEX Expands Its iChemistry? Solutions Portfolio With Sensitivity-enhancing Reagents for Mass Spectrometry05-21-12
Adayana Announces New President05-21-12
Former Secretaries of the Treasury to Deliver Keynote at the 2012 BIO International Convention05-21-12
Enginasion Partners with TransCytos to Develop Breakthrough ?Transfection? Technology for Genetic Engineering Applications05-21-12
Dendreon Announces Data Presentation at the 2012 American Urological Association Annual Meeting05-21-12
Thermo Fisher Scientific Introduces New Nano-Flow LC-MS Solution at ASMS 201205-21-12
Thermo Fisher Scientific Announces Expanded Portfolio of Applications Software for the Q Exactive Mass Spectrometer at ASMS 201205-21-12
Thermo Fisher Scientific Launches New Triple Quadrupole GC-MS System at ASMS 201205-21-12
Thermo Fisher Scientific Adds Large Molecule Functionality to its Industry-Leading LIMS for Bioanalytical Laboratories05-21-12
Thermo Fisher Scientific Showcases Data Processing Software for Analyzing Dioxins and Other Persistent Organic Pollutants at ASMS 201205-21-12
Thermo Fisher Scientific Introduces Next-Generation Benchtop LC-MS System at ASMS 201205-21-12
Thermo Fisher Scientific Highlights New Sample Preparation Products for the Mass Spectrometry Workflow at ASMS 201205-21-12
Thermo Fisher Scientific Features Versatile Gas Chromatograph Series at ASMS 201205-21-12
Thermo Fisher Scientific Highlights New Chromatography Columns and Consumables at ASMS 201205-21-12
Peru's Largest Pharmacy Chain, InkaFarma, Selects and Implements LogFire Cloud-Based SaaS WMS to Gain Efficiency and Productivity05-21-12
BioTime Completes Merger of XenneX, Inc. into LifeMap Sciences, Inc.05-21-12
SOMARK Innovations Launches New TriCellTM Technology for the LabstampTM System at the 59th Annual Meeting of JALAS05-21-12
iPierian Appoints Pamela B. Conley as Vice President of Research05-21-12
Cook Medical Launches First Drug-Eluting Stent in Australia to Treat Peripheral Arterial Disease (PAD)05-21-12
iPierian Advances Monoclonal Antibody Drug Development Programs Targeting Tau Protein and the Complement System for the Treatment of Neurodegenerative Diseases05-21-12
Three Abstracts on the ChemoFx® Drug Response Marker Accepted by ASCO05-21-12
Lundbeck and CHDI Foundation Announce Research Collaboration to Investigate Candidate Therapy for Huntington's Disease05-21-12
For Moderate to Severe Psoriasis, Surveyed U.S. Dermatologists Would Accept a Substantial Decrease in Efficacy Compared with Enbrel in Order to Have an Oral Therapy with a Lower Rate of Serious Infection and Comparable Safety Profile05-21-12
Since Gaining European Authority Approval for Victrelis in July and Incivo in September, Protease Inhibitor Share Has Penetrated Nearly One-Third of the Genotype 1 Market and is Anticipated to Significantly Increase Over the Next Six Months05-21-12
Digestive Disease Week Presentations Support Therapeutic Potential for Gattex (teduglutide) as Novel Treatment for Adult Short Bowel Syndrome05-21-12
Market-Leading Pharmaceutical Services Provider Deploying Impact 360 for Back-Office Operations Software from Verint05-21-12
AltheRx Presents Positive Phase II Results of Solabegron in Overactive Bladder at the American Urological Association Annual Meeting05-21-12
Opexa Therapeutics Announces TcelnaTM as New Brand Name for MS Therapy05-21-12
Makucell? Appoints International Life Sciences Business Leader and Chairman of the Pasadena Angels, Kevin J. Scanlon, Ph.D., to Its Board of Advisors05-21-12
Pacira Pharmaceuticals, Inc. to Be Added to NASDAQ Biotechnology Index05-21-12
Research and Markets: Comparisons of Pharmaceutical Manufacturing between China and India - The Two Most Dynamic Emerging Countries05-21-12
Bruker Announces the New ultrafleXtreme MALDI-TOF/TOF Mass Spectrometer for Novel Applications Achievements Far Beyond Traditional Boundaries05-21-12
Emergent BioSolutions Announces Stock Repurchase Program05-21-12
National Institute for Health Research, Clinical Research Network: New survey shows state of research in NHS05-21-12
Ideal Cures Pvt. Ltd: Ideal Cures Introduces ? Natural Sodium alginate based delayed release formulations System05-21-12
600 patients recrutés dans l?étude clinique de phase III d?Ipsen et d?Active Biotech avec le tasquinimod05-21-12
600 Patients Recruited in Active Biotech's and Ipsen's tasquinimod Clinical Phase III Study05-21-12
???????????????????????????????????/???????05-21-12
Dr. Reddy's Announces the Launch of Over-the-Counter Lansoprazole Delayed-Release Capsules05-21-12
Cellectis stem cells today proudly announces the launch of the world's very first human iPS cell-derived hepatocyte product05-21-12
Cellectis stem cells est fier d?annoncer le lancement du premier produit de type hépatocyte dérivé de cellules souches iPS humaines05-21-12
Shimadzu Corporation führt ultraschnelles Triple-Quadrupol-Gaschromatographen-Massenspektrometer ein und erweitert das LC-MS/MS-Produktportfolio05-21-12
Shimadzu Corporation présente un instrument de chromatographie en phase gazeuse ultra rapide couplé à un spectromètre de masse de type triple quadripôle et élargit la gamme de LC-MS/MS05-21-12
Samenvatting: Shimadzu Corporation introduceert massa-spectrometer en breidt LC-MS/MS portfolio uit05-21-12
Resumen: Shimadzu Corporation presenta la cromatografía de gases-espectrómetro de masas cuadripolar triple y amplía su cartera LC-MS/MS05-21-12
Riassunto: Shimadzu Corporation presenta uno spettrometro di massa/gascromatografo a triplo quadrupolo ultraveloce, ampliando così la propria offerta in campo LC-MS/MS (liquido cromatografia-spettrografia di massa/spettrografia di massa)05-21-12
Cobiprostone Preclinical Data from NSAID-Induced Gastric Mucosal Injury Models Reported at Digestive Disease Week 201205-20-12
Sucampo Presents Data for AMITIZA® in the Treatment of Moderate to Very Severe Irritable Bowel Syndrome with Constipation (IBS-C)05-20-12
BioMed ISRAEL 2012: 15 Delegations from around the World, More Than 6,000 Visitors (1,000 Are Attendees from Abroad) Come This Week to Israel to Meet with the Hottest BioMed Companies in Israel05-20-12
PA32540 Provides Faster Gastric Acid Reduction Than Enteric-Coated Omeprazole (40 mg)05-19-12
Introducing Ohio Biomedical Companies to Job Seekers, Face-to-Face05-18-12
Taro to Announce Financial Results for the Quarter Ended March 31, 201205-18-12
Research and Markets: 2012 Global Tuberculosis Diagnostics Market Outlook: Test Volumes, Sales Forecasts, and Supplier Shares by Country Out Now05-18-12
Research and Markets: Erythropoietin Market in Japan 2011-2015 - The Erythropoietin Market in Japan to Reach US$1.54 Billion By 201505-18-12
Samenvatting: Bionest publiceert artikel over kwantitatieve financiële analyse van gepersonaliseerde medicijnenstrategieën05-18-12
Celldex Therapeutics to Host Call to Announce Topline Results from the EMERGE Study in Advanced Breast Cancer05-18-12
Company Profile for Precision Therapeutics, Inc.05-18-12
Cannabis Science Supports Judge Gustin L. Reichbach's ?Plea for Pot? in New York Times Op-Ed for his Pancreatic Cancer05-18-12
Novo Nordisk Celebrates New INDYCAR Partnership Featuring Indy 500-Themed Billboard in Times Square05-18-12
Pfizer Exploratory Study Measures Effects Of Lyrica (pregabalin) On Brain Activity In Fibromyalgia Patients05-18-12
Advanced Cell Technology to Present at World Stem Cells & Regenerative Medicine Congress in London05-18-12
New York Biotechnology Association to Honor Regeneron Founders as Business Leaders of the Year05-18-12
InVivo Therapeutics? CEO Frank Reynolds Scheduled to Appear on Austin News Today Weekend and Detroit's 7 Action News This Weekend05-18-12
Forest and Almirall to Present Aclidinium Bromide Clinical Data at the American Thoracic Society (ATS) International Conference05-18-12
Research and Markets: Tolcapone (CAS 134308-13-7) Market Research Report 201105-18-12
Veröffentlichung einer neuen Risikostratifizierungsanalyse für TYSABRI® im New England Journal of Medicine05-18-12
Nuova analisi della stratificazione del rischio per TYSABRI® pubblicata nel New England Journal of Medicine05-18-12
Salix Pharmaceuticals Outlines Data Presentations at Digestive Disease Week 201205-18-12
Bionest Publishes Landmark Article on Quantitative Financial Analysis of Personalized Medicine Strategies05-18-12
Bionest publie un article important sur l'analyse financière quantitative des stratégies de médecine personnalisée05-18-12
Riassunto: Bionest pubblica articolo storico su analisi finanziaria quantitativa di strategie mediche personalizzate05-18-12
Bionest veröffentlicht richtungsweisenden Artikel über die quantitative Finanzanalyse von Strategien der personalisierten Medizin05-18-12
Resumen: Bionest publica un artículo revelador sobre el análisis financiero cuantitativo de las estrategias de medicina personalizada05-18-12
Nuevo análisis de la estratificación del riego para TYSABRI® publicados en el New England Journal of Medicine05-18-12
Shimadzu Corporation Introduces Ultra Fast Triple Quadrupole Gas Chromatograph Mass Spectrometer and Expands LC-MS/MS Portfolio05-18-12
Nouvelle analyse de classification du risque associé à TYSABRI® publiée dans le New England Journal of Medicine05-18-12
Santarus Announces Presentation of UCERIS Phase III Extended Use Data at Digestive Disease Week Meeting05-18-12
Dr. Reddy's Announces the Launch of Clopidogrel Tablets, USP05-18-12
Active Biotech et Ipsen présentent les données de survie globale de l?étude de phase II de tasquinimod au Congrès annuel de l?ASCO 201205-18-12
Active Biotech and Ipsen to Present Tasquinimod Phase II Overall Survival Data at the 2012 ASCO Annual Meeting05-18-12
World's First Approved Stem Cell Drug; Osiris Receives Marketing Clearance from Health Canada for Prochymal05-17-12
New Analysis of Risk Stratification for TYSABRI® Published in New England Journal of Medicine05-17-12
Magellan Health Services to Present at Goldman Sachs 33rd Annual Global Healthcare Conference05-17-12
Bio-Path Holdings Reports First Quarter 2012 Operational and Financial Results05-17-12
Avraham Pharmaceuticals Announces Commencement of a Phase 2 Study of Ladostigil for the Treatment of MCI05-17-12
Devon Medical Products Announces Strategic Alliance with PKUcare BeiYi Pharmaceutical Co. to Distribute U.S.-Made Medical Products in China05-17-12
MAHCP, MedImpact to Present Case Study on URx Value-Based Pharmacy Benefit Program05-17-12
Research and Markets: Active Pharmaceutical Ingredients in Italy05-17-12
Thirteenth Annual eHealthcare Leadership Awards Features 14 Categories to Recognize Outstanding Websites and Digital Communications05-17-12
Sigmoid Pharma Completes Phase II trial of CyCol? in more than 100 Ulcerative Colitis Patients and Raises ?3 million05-17-12
Technologie von St. Jude Medical für renale Denervierung sorgt für signifikante Senkung des Blutdrucks05-17-12
Magellan Health Services Named as Finalist for Best Practices in Health Care Consumer Empowerment and Protection Award from URAC05-17-12
Exact Sciences Extends, Expands Relationship with Mayo Clinic05-17-12
Solantic Partners with PatientPoint to Transform the Patient Experience in Urgent Care05-17-12
Alkermes plc Reports Results for Fiscal 2012 and Provides Expectations for Fiscal 201305-17-12
Spectrum Pharmaceuticals Commences Phase 2 Study of ZEVALIN® in Combination with the Redox Modulating Agent Motexafin Gadolinium (MGd)05-17-12
KYTHERA Biopharmaceuticals Files Registration Statement for Proposed Initial Public Offering05-17-12
Positive Phase 2 Clinical Data with Tivantinib in Hepatocellular Carcinoma to Be Highlighted in Oral Presentation at 2012 Annual Meeting of American Society of Clinical Oncology05-17-12
Affymetrix and ScreenCell Announce Worldwide Distribution Agreement for Circulating Tumor Cell (CTC) Technology05-17-12
While U.S. Patients Report High Levels of Satisfaction with Current DMAs, Switching Interest is Highest among Patients for Sanofi / Genzyme's Teriflunomide and Biogen Idec's BG-12, According to a Recent BioTrends Report05-17-12
PerkinElmer Showcases Direct Sample Analysis (DSA) Solutions for Mass Spectrometry at the American Society for Mass Spectrometry (ASMS) Conference05-17-12
Celerion Announces Expanded State-of-the-Art ADME Suite in Its Lincoln, Nebraska USA Facility05-17-12
pSivida Corp. Announces Expiration of 2.7 Million Warrants05-17-12
Tokai Pharmaceuticals? Galeterone Phase 1 Data in Patients with Advanced Prostate Cancer to be Presented at ASCO Annual Meeting 201205-17-12
Puma Biotechnology to Present Clinical Data on PB272 at ASCO 2012 Annual Meeting05-17-12
Angiochem Announces Presentations at Three Upcoming Conferences05-17-12
The Crohn's and Colitis Foundation of Canada and Vertex Announce Collaboration to Fund Research in Inflammatory Bowel Disease05-17-12
The UM Miller School of Medicine Wins Prestigious Designation as Center for AIDS Research05-17-12
SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CITI 2012 GLOBAL CONSUMER CONFERENCE05-17-12
La Fondation canadienne des maladies inflammatoires de l?intestin et Vertex annoncent leur collaboration dans le but de financer la recherche sur les maladies inflammatoires de l?intestin05-17-12
China Jo-Jo Drugstores Announces New Store Openings in Shanghai and Hangzhou05-17-12
MedPro Safety Products to Participate in Two Key Industry Conferences05-17-12
Synta Announces Presentations at the 2012 American Society for Clinical Oncology (ASCO) Annual Meeting05-17-12
Riassunto: La tecnologia di denervazione renale di St. Jude Medical si dimostra in grado di ridurre in misura significativa la pressione arteriosa05-17-12
Resumen: PSE: la nueva tecnología tiene el potencial de transformar la fabricación farmacéutica05-17-12
University Health Network Selects Lexicomp as Drug Information Resource05-17-12
Le Réseau universitaire de santé choisit Lexicomp comme ressource de renseignements sur les médicaments05-17-12
Omega-3 Green-Lipped Mussel Extract May Benefit Joint Pain And Mobility Better Than Fish Oil05-17-12
Pivotal study on afatinib may challenge current standard first line treatment1 for lung cancer patients with EGFR mutations05-17-12
PSE : une nouvelle technologie a le potentiel de transformer la fabrication des produits pharmaceutiques05-17-12
Riassunto: PSE: una nuova tecnologia dispone del potenziale per trasformare la produzione farmaceutica05-16-12
PSE: Neue Technologie hat Potenzial, die Pharma-Herstellung zu transformieren05-16-12
Astellas & AVEO: Tivozanib Successfully Demonstrates the Longest Reported Progression-Free Survival in First Line Metastatic Renal Cell Carcinoma (RCC)105-16-12
Ariad Announces Updated Findings from Pivotal Pace Trial of Ponatinib to Be Presented at Annual Meeting of American Society of Clinical Oncology05-16-12
Dendreon Announces Presentation of PROVENGE Data at the 2012 American Society of Clinical Oncology Annual Meeting05-16-12
AVEO and Astellas Announce Positive Findings from TIVO-1 Superiority Study of Tivozanib in First-Line Advanced RCC05-16-12
Seattle Genetics to Present ADCETRIS® and ASG-5ME Data at ASCO Annual Meeting05-16-12
Array BioPharma Announces Clinical Data Presentations at the 2012 ASCO Annual Meeting05-16-12
CytoDyn Announces Plans to Move Forward with Next Stage of Research of CytoFeline?05-16-12
Panel of Top Industry Executives to Discuss Biotech and Big Pharma ? What's Next? ? 2012 BIO International Convention Keynote05-16-12
Tommy G. Thompson, Former U.S. Secretary of Health and Human Services, Joins TherapeuticsMD, Inc. as Chairman05-16-12
Scientia Advisors? Patrick Terry to be featured speaker at the Genome-wide Partnering and Deal-making Conference05-16-12
PSE: New Technology Has Potential to Transform Pharma Manufacture05-16-12
HealthPartners launches Empower HSA Rx Plus05-16-12
2012???ChinaBio®????????????05-16-12
Ra Pharmaceuticals Unveils Hereditary Angioedema as Lead Program Leveraging Its Cyclomimetic Discovery Platform05-16-12
The French Competitiveness Health Cluster EUROBIOMED is proud to announce that a delegation of SMEs members will attend the ?Israel Biomed 2012? on 21st-23rd May 2012, in Tel-Aviv05-16-12
Oramed Pharmaceuticals Granted Israeli Patent for Its Core Technology in Oral Delivery of Proteins05-16-12
Research and Markets: Scar - Pipeline Review, H1 201205-16-12
Research and Markets: Wounds - Pipeline Review, H1 201205-16-12
Covidien conclui aquisição da superDimension, Ltd.05-16-12
Herbalife Ltd. to Present at the Janney Consumer Conference05-16-12
Biovest Retains Ferghana Partners to Evaluate Strategic Transactions05-16-12
Research and Markets: Autoimmune Disorders Therapeutics Market to 2017 - Launch of Gilenya and Benlysta to Drive the Growth of Multiple Sclerosis and Systemic Lupus Erythematosus Therapeutic Segments05-16-12
Samenvatting: Covidien rondt overname superDimension af05-16-12
Covidien??'superDimension, Ltd.???05-16-12
Michael Jacobs, R.Ph., Joins Truveris Inc., Bringing Years of Pharmacy Expertise to PBM Claims Data and RFP Management Company05-16-12
DiscoveRx Introduces a High-Throughput Biochemical Screening Platform for Bromodomain Epigenetic ?Reader? Proteins05-16-12
Viropro, Inc. to Unlock Value from its Biosimilars Portfolio05-16-12
FINRA Warns Investors of Nutraceutical Stock Scams05-16-12
Research and Markets: Bronchiolitis - Pipeline Review, H1 201205-16-12
Resumen: Nuevo estudio de Fase III confirma que el extracto especial de Ginkgo biloba, EGb 761®, mejora considerablemente las capacidades cognitivas y los síntomas neuropsiquiátricos en enfermedades cognitivas05-16-12
?????????????????????????05-16-12
Merck to Present at Bank of America Merrill Lynch 2012 Healthcare Conference05-16-12
Dyax Corp. Reaffirms Commitment to Supporting Patients with Hereditary Angioedema on Inaugural HAE Day05-16-12
La technologie de dénervation rénale de St. Jude Medical démontre une réduction significative de la pression artérielle05-16-12
The Biodesign Institute® at Arizona State University taps HighRes Biosolutions for simplifying upstream sample preparation of protein microarrays05-16-12
Pulmatrix Announces Presentations at ATS 2012 International Conference05-16-12
Baxter Announces ADVATE Approval in China for the Treatment of Hemophilia A05-16-12
Cubist Pharmaceuticals Marks 20th Anniversary by Making Its Largest-Ever Commitment to STEM Programs05-16-12
Even as UCB's Keppra Captures the Largest Patient Share, Followed by GSK's Lamictal, Strong Company Support and Positive Efficacy Performance Drive Uptake of UCB's Vimpat in the Epilepsy Market, According to a Recent BioTrends Report05-16-12
Research and Markets: Regulation of Pharmaceutical Manufacturers - A Valuable Guide for Pharmaceutical Lawyers05-16-12
Covidien cierra la compra de superDimension, Ltd.05-16-12
NanoString Initiates Second Clinical Validation Study for Breast Cancer Assay05-16-12
Elixir Medical Announces Excellent Results from DESolve I First-In-Man Study for the Fully Bioresorbable Drug Eluting Coronary Scaffold System05-16-12
InVivo Therapeutics Chief Science Officer Edward Wirth to Discuss Biopolymers and Hydrogels for SCI at Rick Hansen's Interdependence 201205-16-12
Reminder: Exelixis Announces Data Presentations, Webcast of Investor Briefing in Conjunction With 2012 ASCO Annual Meeting05-16-12
Nolato Medical and AlpVision Announce Joint Collaboration to Protect Pharmaceutical Primary Packaging and Medical Devices05-16-12
Covidien schließt Übernahme von superDimension, Ltd. ab05-16-12
MDxHealth Provides First Quarter 2012 Business Update05-16-12
MDxHealth présente ses résultats du premier trimestre 201205-16-12
Renal Denervation Technology from St. Jude Medical Demonstrates Significant Reduction in Blood Pressure05-16-12
Genentech Will Report New Data on Important Progress for People with Advanced Cancers at ASCO 201205-16-12
Riassunto: Covidien completa l?acquisizione di superDimension, Ltd.05-16-12
Covidien finalise l'acquisition de superDimension, Ltd.05-16-12
Covidien Completes Acquisition of superDimension, Ltd.05-15-12
Achaogen Announces All Objectives Met in Phase 2 Plazomicin Complicated Urinary Tract Infections Study and Start of First-in-Human Study with ACHN-97505-15-12
Research and Markets: Tension -Type Headache Global Clinical Trials Review, H1, 2012 Provides Briefing Pertaining To the Number of Trials for the Key Drugs for Treating Tension-Type Headache05-15-12
Research and Markets: Pharmaceutical Industry in China - PEST Framework Analysis05-15-12
Research and Markets: The Global Botox Market Is Forecast To Reach $2.9 Billion by 2018 at A CAGR Of 14% Says New Report05-15-12
Galectin Therapeutics Announces Initiation of Phase 1/2 Trial of Novel Combination Therapy for Advanced Metastatic Melanoma05-15-12
Rite Aid Completes Add-on Offering of 9.25% Senior Notes Due 202005-15-12
ABMC Reports First Quarter 2012 Results05-15-12
Research and Markets: Nausea - Pipeline Review, H1 2012 - A Snapshot of the Global Therapeutic Scenario for Nausea05-15-12
Hospitals Launch Program to Prevent Pressure Ulcers as a Part of Federal Initiative05-15-12
Walgreens Launches New and Improved Prescription Savings Club as Approximately 1 in 4 U.S. Adults Lack Adequate Prescription Drug Coverage05-15-12
Theraclone Sciences Announces Positive Top-line Data from a Phase 1 Trial of its Therapeutic Antibody Directed at Influenza A05-15-12
For the Treatment of Osteoarthritic Pain, Clinical Data and Interviewed Thought Leaders Indicate That Tanezumab Has Advantages Over Celebrex05-15-12
Pulmatrix Demonstrates iSPERSE Capabilities for Inhaled Dry Powder Delivery of Antibiotics and Antibodies05-15-12
ACADIA Pharmaceuticals to Webcast Educational Program on Parkinson's Disease Psychosis on May 22, 201205-15-12
Research and License Agreements between National Cheng Kung University and Novo Nordisk A/S05-15-12
SNBL USA Expands Its Social Housing Program05-15-12
Celldex Therapeutics Added to Nasdaq Biotechnology Index05-15-12
Promedior Appoints Suzanne L. Bruhn, Ph.D., as President and Chief Executive Officer05-15-12
Bristol-Myers Squibb Foundation Announces $15 Million Expansion of Together on Diabetes® to China and India05-15-12
DiaGenic awarded research grant of NOK 7.8 million for further development of DiaGenics tests for early detection of Alzheimer's disease05-15-12
Research and Markets: Gabon Pharmaceuticals and Healthcare Report Q2 201205-15-12
Derma Sciences Reports First Quarter 2012 Financial Results05-15-12
Infinity Added to NASDAQ Biotechnology Index05-15-12
IGI Laboratories Announces 1st Quarter 2012 Results05-15-12
Thermo Fisher Scientific Acquires All Rights for Pre-eclampsia Biomarker from Nephromics05-15-12
Pernix Therapeutics Reports First Quarter 2012 Financial Results05-15-12
BioLineRx Reports First Quarter 2012 Results05-15-12
Liquidia Studies Show PRINT® Engineered Particles Hold Promise in the Delivery of Respiratory Therapeutics05-15-12
Samenvatting: Nieuwe fase III studie: Ginkgo biloba speciale extracte EGb 761 verbetert aanzienlijk cognitieve en neuropsychiatrische symptomen05-15-12
MWV Healthcare to Present at Inaugural Pharmapack North America Conference05-15-12
CytRx Announces Reverse Stock Split05-15-12
Accelr8 and Denver Health Notified by Department of Defense for Rapid Diagnostics Award05-15-12
InVivo Therapeutics Reports First Quarter 2012 Financial Results, Provides Business Update05-15-12
Research and Markets: Partnerships, Licensing, Investments and M&A Deals and Trends for Q1 2012 in Pharmaceuticals05-15-12
Research and Markets: Tensions Rising between Branded Drugmakers and Health Plans - The Co-Pay Coupon Lawsuit and the Implications05-15-12
BroadcastMed Highlights Wound Therapy Technology05-15-12
Antares Pharma Appoints LeRoux Jooste Senior Vice President Pharmaceutical Sales and Marketing05-15-12
NeuroMetrix Announces WellMed Medical Management's Integration of NC-stat® DPNCheck? Into Their Patient Evaluation Program05-15-12
Gamida Cell Closes $10 Million E Financing Round Earmarked to Support the Global Commercialization of the Company's Lead Product StemEx® for Leukemia and Lymphoma05-15-12
Samenvatting: Galderma Italy rolt Mobile Intelligence for iPad en OneKey van Cegedim Relationship Management uit05-15-12
Lab21 Secures European and USA Patents for HCV Drug Resistance Genotyping05-15-12
Medivir: New Executive Vice President Commercial Appointed05-15-12
Scil Proteins Enters Drug Discovery Collaboration with Ono for Affilin® Therapeutics05-15-12
Neue Phase-III-Studie bestätigt: Ginkgo-biloba-Spezialextrakt EGb 761® verbessert deutlich Kognitionsfähigkeiten und lindert signifikant neuropsychiatrische Symptome bei kognitiven Störungen05-15-12
Aptiv Solutions Announces the Appointment of Luis Gutierrez as Executive Vice President and Chief Commercial Officer05-15-12
DBV Technologies : Chiffre d?affaires du 1er trimestre, activité scientifique et données cliniques à venir05-15-12
DBV Technologies: First Quarter 2012 Topline, Scientific Activity and Upcoming Clinical Data05-15-12
Partnering Bootcamp Kicks Off ChinaBio® Partnering Forum 2012 in Suzhou05-14-12
Une nouvelle étude de phase III confirme que l'extrait spécial de ginkgo biloba EGb 761® améliore notablement les capacités cognitives et les symptômes neuropsychiatriques dans les troubles cognitifs05-15-12
Array BioPharma and Genentech's Strategic Alliance Voted Breakthrough Alliance of 201205-14-12
Cubist Announces First Scientific Presentations of Phase 2 Data for CB-5945 in the Treatment of Opioid-Induced Constipation05-14-12
Lahey Clinic Joins Blue Cross Blue Shield of Massachusetts Alternative Quality Contract05-14-12
Aetna Pharmacy Management Introduces Five New Patient Safety Programs05-14-12
Medgenics Announces First Quarter 2012 Financial Results05-14-12
BioScrip to Present at Bank of America Merrill Lynch 2012 Health Care Conference05-14-12
GREER® Announces Veterinary Partnership with IDEXX Reference Laboratories05-14-12
Almac Adds High-Speed Clinical Trial Blistering Equipment at US HQ05-14-12
Galderma Italy Deploys Comprehensive Cegedim Relationship Management Cloud-Based Solution Including Award-Winning* Mobile Intelligence for iPad? and OneKey? Database05-14-12
Riassunto: Galderma Italia implementa la soluzione completa CRM cloud-based che comprende il pluripremiato* Mobile Intelligence for iPad? e il database OneKey?05-14-12
Galderma Italia implementiert umfassende Cloud-basierte Lösung von Cegedim Relationship Management, darunter das preisgekrönte* Mobile Intelligence for iPad? und die OneKey?-Datenbank05-14-12
BioAlliance Pharma SA: Démarrage de ReLive, essai clinique de phase III de Livatag® dans le cancer primitif du foie05-14-12
Laboratorios Casen Fleet déploie la solution primée* Mobile Intelligence pour iPad? de Cegedim Relationship Management, en mode Cloud05-14-12
CORRECTING and REPLACING Ligand to Present at the Jefferies 2012 Global Healthcare Conference on June 405-14-12
Resumen: Galderma Italia implementa la galardonada solución de Cegedim Relationship Management en la nube Mobile Intelligence para iPad TM con la base de datos OneKey TM05-14-12
Axial Exchange Showcases How Touch-Screen Solutions Can Reduce Avoidable Readmissions05-14-12
Helicos BioSciences Corporation Settles its Patent Litigation Against Pacific Biosciences, Inc.05-14-12
Acurian Reports Record First Quarter as a Result of Growing Demand for Its Patient Enrollment, Retention and Oncology Services05-14-12
Growing Talent, Recognizing Ability: Walgreens Launches National Initiative to Help Create More Job Opportunities for People with Disabilities05-14-12
PharMerica to Present at the Bank of America Merrill Lynch 2012 Health Care Conference05-14-12
New Phase III study confirms: Ginkgo biloba special extract EGb 761® significantly improves cognition and neuropsychiatric symptoms in cognitive disorders05-14-12
Research and Markets: Stem Cell Research Products: Opportunities, Tools & Technologies 2012 (Updated)05-14-12
HyStem®-C Demonstrated Effective when Formulated with Human Heart Cells and Transplanted in an Animal Model of Heart Disease05-14-12
Cellerant Announces Publication Demonstrating Significant Survival Benefits and Preclinical Proof of Concept With Myeloid Progenitors as Radiation Countermeasure05-14-12
Maxygen to Receive $30 Million Payment from Bayer05-14-12
Leading Specialty Pharmaceutical Company to Implement Ross Enterprise05-14-12
Resumen: Pixuvri® de CellTherapeutics aprobado en Estados Unidos como monoterapia para el tratamiento de pacientes adultos con linfomas de células B no Hodgkin agresivo refractario o recurrente múltiple05-14-12
Samenvatting: Cell Therapeutics krijgt EU-goedkeuring voor Pixuvri voor behandeling patiënten met non-Hodgkin B-cellymfomen05-14-12
Histogenics? NeoCart for Patients with Knee Cartilage Damage Demonstrates Continued Efficacy for Periods of Up to Five Years05-14-12
NanoViricides Appoints Mr. Andrew Hahn as Consultant for Design and Construction of Pilot cGMP Production Facility05-14-12
Following the Release of Detailed Results from the CONFIRM Study at the 64th Annual Meeting of the American Academy of Neurology, 90 Percent of Surveyed U.S. Neurologists Report Willingness to Prescribe Biogen Idec's BG-1205-14-12
New ClearTrial Video Featuring Leading Analyst Firm Offers Insights into Improving R&D Efficiency and Productivity05-14-12
Pfizer To Present New Data In Advanced Kidney, Lung And Hematologic Cancers At 2012 ASCO Annual Meeting05-14-12
Ironwood and Forest to Present 17 Linaclotide-Related Abstracts at Digestive Disease Week® 201205-14-12
Bristol-Myers Squibb to Present New Data on ORENCIA® (abatacept) at the European League Against Rheumatism (EULAR) 2012 Congress05-14-12
Verastem, Inc. Reports First Quarter 2012 Financial Results05-14-12
Ligand to Present at the Jefferies 2011 Global Healthcare Conference on June 405-14-12
?????????????????????????I???????????2???3?????????????????????????????05-14-12
Provectus Pharmaceuticals Forms Independent Board to Meet Corporate Governance Requirements05-14-12
Samenvatting: Laboratorios Casen Fleet gaat aan de slag met 'Mobile Intelligence for iPad' van Cegedim Relationship Management05-14-12
Resumen: SLA Pharma AG anuncia importantes resultados desde el punto de vista clínico y estadístico del estudio de fase 2 para el estreñimiento inducido por opioides05-14-12
Samenvatting: SLA Pharma AG publiceert data fase 2 op 'Opioid Induced Constipation'05-14-12
SLA Pharma AG Announces Clinically and Statistically Significant Phase 2 Results on Opioid Induced Constipation05-14-12
Riassunto: SLA Pharma AG annuncia risultati di fase 2 clinicamente e statisticamente significativi sulla costipazione indotta da oppioidi05-14-12
SLA Pharma AG gibt klinisch bedeutsame und statistisch signifikante Ergebnisse ihrer Phase-2-Studie zur opioidinduzierten Obstipation bekannt05-14-12
SLA Pharma AG annonce des résultats de phase 2 cliniquement et statistiquement significatifs pour la constipation induite par les opioïdes05-14-12
AIS HMI Terminals Optimize Cleaning-in-Place for Food and Beverage Industry05-14-12
Heel Supports New International Research Prize in Integrative Medicine05-14-12
Pixuvri® von CellTherapeutics in der EU als Monotherapie zur Behandlung erwachsener Patienten mit mehrfach rezidivierendem oder refraktärem aggressivem Non-Hodgkin-B-Zell-Lymphom zugelassen05-11-12
Galectin Therapeutics Reports First Quarter 2012 Financial Results05-11-12
Paragon Sponsors CBI Conference on Electronic Trial Master File Implementation05-11-12
Research and Markets: Global Epinephrine Market 2011-2015 Report Discusses That Shortage of Drug Supply to Meet Demand Hampers the Growth of the Market Worldwide05-11-12
Taro 2011 Annual Report on Form 20-F Available05-11-12
Research and Markets: Drug and Medical Device Product Liability Deskbook05-11-12
Derma Sciences to Present at the Bank of America Merrill Lynch 2012 Health Care Conference05-11-12
Pixuvri di CellTherapeutics approvato nell?UE come monoterapia per il trattamento di pazienti adulti affetti da linfomi Non-Hodgkin a cellule B aggressivi recidivanti o refrattari multipli05-11-12
CellTherapeutics? Pixuvri® Approved in EU as Monotherapy to Treat Adult Patients with Multiply Relapsed or Refractory Aggressive Non-Hodgkin B-Cell Lymphomas05-11-12
Research and Markets: Global Gastric Cancer Drug Pipeline Capsule - 201205-11-12
Research and Markets: Global Malignant Melanoma Drug Pipeline Capsule - 201205-11-12
Lannett Company Adds Paul Taveira to Board of Directors05-11-12
Arno Therapeutics Announces Orphan-Drug Designation for AR-42 in Europe05-11-12
The 10th Endocrine Regulation Prize of the Fondation Ipsen is awarded to Paolo Sassone-Corsi05-11-12
Osiris Therapeutics Reports First Quarter 2012 Financial Results05-11-12
AmerisourceBergen Names Tim G. Guttman Senior Vice President and Chief Financial Officer05-11-12
Le 10ème Prix Régulations Endocriniennes de la Fondation Ipsen est décerné à Paolo Sassone-Corsi05-11-12
Seattle Genetics to Present at Bank of America Merrill Lynch Health Care Conference05-11-12
InVivo Therapeutics Adds Senior Leadership in Manufacturing and Cell Research05-11-12
Cell Signaling Technology, Inc. Develops Novel Monoclonal Antibody Discovery Platform05-11-12
Dr. Reddy's Revenues Cross $2 Billion Milestone* in FY1205-11-12
Dyax Corp. Launches Hereditary Angioedema (HAE) Attack Tracker?, a Free iPhone Application for HAE Patients05-11-12
Aradigm Announces First Quarter 2012 Financial Results05-11-12
Notice of Annual General Meeting of Karo Bio AB (Publ)05-11-12
Research and Markets: Taxol (Breast Cancer) - Analysis and Forecasts to 202005-11-12
La société bordelaise eDevice dévoile le HealthGO, la première plateforme technologique pour le suivi de patients à distance05-11-12
Research and Markets: Cambodia Pharmaceuticals and Healthcare Report Q2 201205-11-12
GE???????????????????????????????05-11-12
Lab21 Unveils New Molecular Analysis Services at Greenville Site05-11-12
Takeda Announces GEMINI II Trial of Vedolizumab in Patients with Moderately to Severely Active Crohn's Disease Met Primary Endpoints of Improvement in Clinical Remission in Induction and Maintenance Phases05-11-12
Laboratorios Rubió Seamlessly Implements the Award Winning* Mobile Intelligence for iPad? Cloud-Based CRM and the Industry Leading OneKey? Healthcare Professional Database05-11-12
CORRECTING and REPLACING Tonix Pharmaceuticals Appoints Dr. Samuel Saks to Its Board of Directors05-11-12
Cardionovum® lanciert zwei Produktfamilien medikamentenfreisetzender Ballondilatationskatheter (DEB) auf der EuroPCR 201205-10-12
Codexis Reports First Quarter 2012 Results05-10-12
Anacor Pharmaceuticals Reports First Quarter 2012 Financial Results05-10-12
Alkermes to Host Conference Call to Discuss Financial Results for Fiscal Year 201205-10-12
CEL-SCI Corporation Reports Second Quarter 2012 Financial Results05-10-12
SDIX Reports First Quarter 2012 Results and First Advanced Genomic Antibody Technology Collaboration with a Major Pharmaceutical Company05-10-12
Exelixis Announces May 17th Webcast of Presentation at the Bank of America Merrill Lynch 2012 Health Care Conference05-10-12
Metabolon's Shanghai Jiao Tong University Lab Receives Validation05-10-12
Research and Markets: Analysis Report to China Pharmaceutical Machinery Industry05-10-12
Onconova Advances Oral Rigosertib to Phase II Clinical Trial in Myelodysplastic Syndromes05-10-12
Research and Markets: OTC Pharmaceuticals in Switzerland05-10-12
Research and Markets: OTC Pharmaceuticals in Israel05-10-12
Cardionovum® Will Launch Two Drug-Eluting Balloon (DEB) Dilatation Catheter Product Families at EuroPCR 201205-10-12
Research and Markets: OTC Pharmaceuticals in Singapore05-10-12
CORRECTING and REPLACING The International Myeloma Foundation Says Three Studies Highlighting Myeloma Treatment-Advances Are Featured Together in the Prestigious New England Journal of Medicine05-10-12
PharMerica to Present at the 11th Annual JMP Securities Research Conference05-10-12
Samenvatting: New England Journal of Medicine: rapport over behandeling REVLIMID (lenalidomide) bij patiënten met multiple myeloma05-10-12
Resumen: New England Journal of Medicine informa sobre tres ensayos de Fase III de REVLIMID® (lenalidomida) en pacientes con mieloma múltiple de reciente diagnóstico05-10-12
Alexion to Present at Bank of America Merrill Lynch 2012 Health Care Conference05-10-12
COPD Foundation Appoints New Staff to Oversee DRIVE4COPD Campaign05-10-12
Resolutions at the annual general meetings in Medivir on 10 May 201205-10-12
Seattle Genetics Announces Data from Investigator Trial of ADCETRIS? in Relapsed Cutaneous T-Cell Lymphoma05-10-12
Samenvatting: GE Healthcare Life Sciences rondt overname Xcellerex af05-10-12
CytRx Reports First Quarter 2012 Financial Results05-10-12
Aerpio Appoints Dr. Adrienne Graves to Board of Directors05-10-12
Tonix Pharmaceuticals Appoints Dr. Samuel Saks to Its Board of Directors05-10-12
Response Genetics, Inc. Announces First Quarter Financial Results05-10-12
GE Healthcare Life Sciences cierra la compra de Xcellerex, Inc.05-10-12
GE Healthcare Life Sciences Completes Acquisition of Xcellerex, Inc.05-10-12
Riassunto: GE Healthcare Life Sciences completa l'acquisizione di Xcellerex, Inc.05-10-12
GE????????????Xcellerex, Inc.???05-10-12
GE Healthcare Life Sciences bringt Akquisition von Xcellerex, Inc. zum Abschluss05-10-12
SYMBICORT® (budesonide/formoterol fumarate dihydrate) Long-Term Study Shows Similar Safety Profile When Compared to Budesonide Monotherapy in African-American Patients with Asthma05-10-12
Impax Laboratories to Present at the Bank of America Merrill Lynch 2012 Health Care Conference05-10-12
GE Healthcare Life Sciences Completa Aquisição da Xcellerex, Inc.05-10-12
American Renal Associates Announces First Quarter 2012 Results05-10-12
GE Healthcare Life Sciences finalise l'acquisition de Xcellerex, Inc.05-10-12
Fitch Publishes 4Q'11 Stats Quarterly Report05-10-12
Research and Markets: Polycythemia Vera Therapeutics - Pipeline Assessment and Market Forecasts to 201905-10-12
Myeloma Canada Highlights Three Clinically Significant Studies Advancing Treatment in the New England Journal of Medicine05-10-12
Riassunto: New England Journal of Medicine rende note tre sperimentazioni di fase III del REVLIMID® (lenalidomide) in pazienti con mieloma multiplo di recente diagnosi05-10-12
New England Journal of Medicine Reports on Three Phase III REVLIMID® (lenalidomide) Trials in Patients with Newly Diagnosed Multiple Myeloma05-10-12
ARIAD to Present at Bank of America Merrill Lynch 2012 Health Care Conference05-10-12
Myélome Canada met en évidence trois études cliniques importantes dans le New England Journal of Medicine qui font progresser le traitement du myélome multiple05-10-12
For the Treatment of Advanced Melanoma, Oncologists Report that Yervoy and Zelboraf have Joined Temodar as the Leading Agents for First-line Therapy05-10-12
TherapeuticsMD, Inc. Launches vitaMedMD RediChew RX, the First Daily Chewable Prescription Prenatal Vitamin with Quatrefolic05-10-12
A.P. Pharma Announces First Quarter 2012 Financial Results and Recent Corporate Progress05-10-12
Somaxon Pharmaceuticals Reports First Quarter 2012 Financial Results05-10-12
Le New England Journal of Medicine publie les résultats de trois essais de phase III de REVLIMID® (lénalidomide) effectués sur des patients atteints de myélome multiple nouvellement diagnostiqué05-10-12
New England Journal of Medicine berichtet über drei Phase-III-Studien zu REVLIMID® (Lenalidomid) an Probanden mit neu diagnostiziertem multiplen Myelom05-10-12
Research and Markets: International Stroke Conference 2012 - Post-Conference Review and Analysis05-10-12

SourceSolution © 2008-2012